Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women
Kars M, Yang L, Gregor MF
Published in Diabetes
Methodology
Randomized placebo-controlled trial of TUDCA 1750 mg/day for 4 weeks in obese men and women with hyperinsulinemic clamp assessment
Key Findings
Hepatic and muscle insulin sensitivity improved by roughly 30% with no change in adipose tissue insulin sensitivity
Conclusions
TUDCA improves hepatic and muscle insulin sensitivity in obesity but does not affect adipose tissue
Limitations
Small sample, 4-week duration, mechanistic endpoints only
Supplements Studied
Hepatic and muscle insulin sensitivity improved by approximately 30% with no change in adipose tissue
Outcomes Measured
TUDCA improved hepatic and muscle but not adipose tissue insulin sensitivity
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.